Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Susmita Roy

Mpharm (Pharmacology)

Susmita Roy, B pharm, M pharm Pharmacology, graduated from Gurunanak Institute of Pharmaceutical Science and Technology with a bachelor's degree in Pharmacy. She is currently working as an assistant professor at Haldia Institute of Pharmacy in West Bengal. She has been part of Medical Dialogues since March 2021.

Home

Susmita Roy

Articles By : Susmita Roy

Azithromycin, Ofloxacin Combos Among 3 Drug Batches Flagged as Purportedly Spurious by CDSCO

CDSCO Flags 5 Batches of Widely Used Drugs Including Azithral-500, Telma-AM as Potentially Spurious

Written By Susmita Roy25 Nov 2025 9:57 PM IST

New Delhi: The Central Drugs Standard Control Organization (CDSCO) has flagged five widely used medicines, including Azithral-500, Telma-AM, Noophin,...

AiMeD Hails CDSCO Medical Device Licensing Mandate but Flags Loophole for Foreign Certifications

Written By Susmita Roy24 Nov 2025 7:28 PM IST

New Delhi: The Association of Indian Medical Device Industry (AiMeD) has welcomed the recent CDSCO directive mandating Indian regulatory licenses for...

Dadachanji Group Enters Medical Devices Space, Launches KAIRISH Innotech

Indian Licensing Now Mandatory for All Medical Device Procurements

Written By Susmita Roy24 Nov 2025 7:20 PM IST

New Delhi: The Central Drugs Standard Control Organization (CDSCO) has issued a crucial directive requiring all procurement agencies including...

State Drug Alert: From Antibiotics to Antihypertensives, 134 Samples Found NSQ in February Audit

CDSCO Flags 63 Drug Batches Including Paracetamol, Dexona as Not of Standard Quality in October

Written By Susmita Roy23 Nov 2025 8:07 PM IST

New Delhi: In a striking reminder of the ongoing challenges in India's pharmaceutical quality ecosystem, 63 batches of widely used medicines have been...

AI Meets Pharma: Novo Nordisk Teams Up with OpenAI for Faster Drug Innovation

CDSCO Panel Reviews Novo Nordisk's PMS Study, Clears Data on Oral Semaglutide

Written By Susmita Roy22 Nov 2025 10:50 PM IST

New Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organization (CDSCO) reviewed the Post Marketing Surveillance...

Centre Mandates QR Codes for Top Medicines, APIs: Minister

Attention Chemists: All Pharmacies to Mandatorily Display PvPI QR Code, ADR Toll-Free Number

Written By Susmita Roy22 Nov 2025 3:22 PM IST

New Delhi: Every chemist and pharmacist in the country will now be required to mandatorily display the Pharmacovigilance Programme of India (PvPI) QR...

Sun Pharma Seals Rs 97,500 Crore Organon Acquisition Deal

No Trial Waiver: CDSCO Panel Directs Sun Pharma to Run Phase III Study for Somatropin Liquid Injection Citing Lack of India-Specific Data

Written By Susmita Roy21 Nov 2025 4:26 PM IST

New Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organization (CDSCO) has opined that the drug major Sun...

Delhi HC Bars Dr Reddys from Selling Olymviq Over Similarity with Novo Nordisks Ozempic

Delhi HC Rejects FMC Plea, Clears Natco to Launch Cyantraniliprole Ahead of Patent Expiry

Written By Susmita Roy21 Nov 2025 4:18 PM IST

New Delhi: Strengthening India's stance on fair market competition in agriculture, the Delhi High Court has denied FMC Corporation's attempt to...

Breaking News: Health Ministry Bans Immediate-Release Nimesulide Oral Doses Above 100 mg

Punjab Bans Mercury Medical Devices Including Thermometers, BP Monitors, Dental Amalgam

Written By Susmita Roy20 Nov 2025 11:19 PM IST

Amritsar: In a major environmental health initiative, the Punjab Health Systems Corporation (PHSC) has mandated a complete withdrawal of all...

Entod Pharma gets CDSCO Panel nod to conduct Phase IV CT of Atropine Sulfate Ophthalmic Solution USP 0.05%

Written By Susmita Roy19 Nov 2025 10:42 PM IST

New Delhi: Approving the proposal for a Phase IV clinical study for Atropine Sulfate Ophthalmic Solution USP 0.05% w/v, the Subject Expert Committee...

Bombay High Court Permits Re-Export of Seized Cosmetic Consignments Imported by Glamstone

Bombay High Court Blocks Use of Deceptively Similar Diabetes Drug Trademark

Written By Susmita Roy19 Nov 2025 10:14 PM IST

Mumbai: In a ruling reinforcing the protection of pharmaceutical trademarks, the Bombay High Court has granted interim relief to Laboratories Griffon,...

CDSCO, DoP Told to Find Workable Solution on Revised Schedule M GMP Concerns

High-Level Ethiopia Delegation Meets DCGI, IPC to Strengthen Pharmaceutical Ties

Written By Susmita Roy18 Nov 2025 6:33 PM IST

New Delhi: In a significant step toward reshaping pharmaceutical cooperation across the Global South, India and Ethiopia have taken concrete strides...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok